Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-04 · accession 0000950170-25-014491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | 2025-02-04 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.65 | -4,099 | 1.12M | -0.4% | -$2,664 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 4,099 | $0.65 | 1,120,158 | D | — | — |